NRX Pharmaceuticals (NRXP) P/E (2018 - 2026)
NRX Pharmaceuticals (NRXP) P/E from Apr 2, 2018 to Jul 20, 2026. The TTM NRX Pharmaceuticals (NRXP) P/E is -3.64. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of NRX Pharmaceuticals (NRXP)
| Year | P/E | Change |
|---|---|---|
| 2026 | -3.64 | +91.78% |
| 2025 | -1.90 | +87.01% |
| 2024 | -1.02 | -8.73% |
| 2023 | -1.11 | +16.04% |
| 2022 | -0.96 | -85.62% |
| 2021 | -6.67 | -99.98% |
| 2020 | -31.72K | -4591.26% |
| 2019 | 706.27 | -81.83% |
| 2018 | 3.89K | N/A |
Comparison NRX Pharmaceuticals (NRXP) P/E with competitors
NRX Pharmaceuticals (NRXP) P/E is -3.64.